NetworkNewsBreaks Archive - Page 522 of 2236

ThursdayMar 14, 2024 1:51 pm

NetworkNewsBreaks — D-Wave Quantum Inc. (NYSE: QBTS) Executives to Participate in 36th Annual Roth Conference

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, announced that CEO Dr. Alan Baratz and CFO John Markovich will present at the 36th Annual Roth Conference. The three-day event is scheduled for March 17–19, 2024, in Dana Point, California. According to the announcement, Dr. Baratz will also participate in a fireside chat scheduled for 1 p.m. PT on March 19. A replay of the fireside chat will be available following the presentation. To register for the fireside chat, visit https://nnw.fm/0oI0J To view the full press…

ThursdayMar 14, 2024 1:49 pm

NetworkNewsBreaks – Correlate Energy Corp. (CIPI), Carbonsight Create Powerful Synergy, Empower Navigation to Low-Carbon Future

Correlate (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, recently announced a strategic partnership with Carbonsight (by Autocase). “This move brings together Carbonsight’s cutting-edge decarbonization planning software and Correlate’s expertise in developing and financing renewable and clean energy projects, together helping businesses transition to a low-carbon future… Carbonsight is an online decarbonization planning tool specifically designed for real estate portfolios. It facilitates the development of building and portfolio plans to achieve carbon reduction targets. This allows building portfolio owners to organize pertinent data, quantify prospective CO2-reducing solutions, and visualize carbon reduction scenarios…

ThursdayMar 14, 2024 8:30 am

NetworkNewsBreaks – Gaxos.ai Inc. (NASDAQ: GXAI) Announces $3.5M Private Placement

Gaxos.ai (NASDAQ: GXAI), a company developing artificial intelligence applications across various sectors, has entered into definitive agreements for a private placement priced at-the-market under Nasdaq rules. The private placement includes the purchase and sale of an aggregate of 628,367 shares of common stock (or pre-funded warrant in lieu thereof), series A warrants to purchase up to 628,367 shares of common stock and short-term series B warrants to purchase up to 628,367 shares of common stock at a price of $5.57 per unit (or per pre-funded warrant in lieu thereof) and accompanying warrants. The series A warrants and short-term series B…

WednesdayMar 13, 2024 4:45 pm

NetworkNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Announces Option to Epworth Property in Nunavut, Canada

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF) recently announced that on Feb. 29, 2024, it entered into a binding letter agreement with Emerald Geological Services (“EGS”) under which it has been granted an option to acquire an undivided 80% beneficial interest in a property owned by EGS in Nunavut, Canada. “We are very excited to option the Epworth Property,” said Thomas Ullrich, CEO of Aston Bay. “This is an impressive 74-kilometre-long trend of high-grade copper, silver and zinc mineralization with accompanying gold, cobalt and lead. This mineralization is in a style typical of the Central African Copper Belt that boasts several…

WednesdayMar 13, 2024 4:38 pm

NetworkNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0) Offers Solutions to Combat Growing Cyber Risks

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a leading Swiss-hosted secure and private communications platform, today outlined solutions to protect enterprise and small to medium-sized business (“SMB”) owners from the growing menace of bad actor cyber threats. Recent incidents, such as the alleged exploitation of Google accounts via OAuth2 functionality and the high-profile hacking of Microsoft’s corporate network from a Russian hacking group, highlight the crucial need for robust cybersecurity and data privacy measures. “As bad actor states continue to escalate their cyber threats, especially in the USA and during a presidential election year, businesses are facing unprecedented…

WednesdayMar 13, 2024 4:32 pm

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Issues Update on US Government Ruling for Class 1 EV Cargo Vans

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today provided an update on the U.S. Customs and Border Protection (“CBP”) application for Class 1 EV cargo vans. According to the announcement, the CBP, on March 5, 2024, informed Rapid Response Defense Systems (“RRDS”) counsel that a final determination on the ruling request needs to be issued by the U.S. General Services Administration (“GSA”). Based on CBP advice, Mullen and RRDS are proceeding with the GSA in order to finalize qualification of Mullen to sell Class 1 EV cargo vans to all branches of the U.S. government. “Mullen is…

WednesdayMar 13, 2024 4:19 pm

NetworkNewsBreaks – HealthLynked Corp. (HLYK) Names Seasoned Financial Expert as New CFO

HealthLynked (OTCQB: HLYK), a pioneering provider of healthcare network and services, has appointed David Rosal as its new chief financial officer, effective March 18, 2024. Rosal has worked at both McDonald’s Corporation and Teradata, accumulating more than two decades of experience in financial planning, business scaling and strategic development. At McDonald’s, Rosal was instrumental in scaling the business, and his leadership was key to the company's growth and operational efficiency across multiple locations. His insight and expertise from this background is “directly relevant to HealthLynked's mission to expand its in-network physician and healthcare service network,” noted the company, which is…

WednesdayMar 13, 2024 4:12 pm

NetworkNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Shares Vision, Innovations in ASD Treatments in Updated Company Presentation

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today announced the release of its latest company presentation. The comprehensive overview showcases PaxMedica’s strategic direction, recent advancements in autism spectrum disorder (“ASD”) therapeutics, and its commitment to addressing unmet needs within the ASD community. “PaxMedica is pleased to share our vision and progress with the wider community,” said Howard Weisman, chairman and CEO of PaxMedica. “We believe that our work has the potential to transform the treatment landscape for ASD, offering a new horizon of hope and support for affected individuals and their loved ones.” To…

WednesdayMar 13, 2024 3:31 pm

NetworkNewsBreaks – ECGI Holdings Inc. (ECGI) Continues Initiative to Achieve Financial Optimization, Unlock Growth Opportunities

ECGI Holdings (OTC: ECGI), a diversified holding company, is continuing its initiative to strengthen its financial structure and boost shareholder value with further advancements. The company noted that it continues to build on its efforts, which have so far resulted in the successful identification and reduction of more than $600,000 in liabilities. The company has now identified an estimated additional $1,500,000 in liabilities for reduction, stemming from its strategic negotiations leading to the cancellation of purchase orders related to the acquisition of the East West Pharma Group. The significant reduction in liabilities and ongoing cleanup of ECGI’s balance sheet is expected to have a…

WednesdayMar 13, 2024 12:20 pm

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces FY 2023 Results, Recent Operating Highlights

Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, today announced its full year 2023 financial results. In addition, the company provided recent operating highlights for the clinical programs in amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”). “In 2024 we will continue to advance our regulatory discussions with the U.S. Food and Drug Administration (‘FDA’) that we anticipate will include new data on biomarkers, as well as additional clinical function and survival data in people…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks